Klyne

💥 Drug discovery software is broken
Customers pay big fees for tools that may not work

👉🏽 We started KlyneAI to build tailored tools for your challenges—not generic ones

No sugar-coating. If it doesn’t work, we stop—you don’t waste money.Time for an honest, problem-driven approach to drug discovery

Check out this hot take from our CTO 👇

At Klyne, we focus on practical, results-driven drug discovery—for most clients, ultra-large virtual screening (trillions of compounds 🌐) makes sense with conventional docking. It’s fast, scalable, and gets the job done

Curious to learn more? [klyne@klyne.ai]

🚀 Big news from Klyne!

We’re thrilled to be collaborating with @cgorgulla.bsky.social ky.social's lab to develop the next generation of tools for accelerating drug discovery.

Stay tuned—some exciting papers are on the way from this collaboration!

🚀 Exciting News! 🚀

KlyneAI is thrilled to join JLABS! We’re pushing the boundaries of biotech innovation and developing cutting-edge tools for drug discovery.

Want to collaborate on AI-driven drug discovery?
→ klyne@klyne.ai

#Biotech #DrugDiscovery #AI #JLabs

(Yes, the view’s amazing) 🤩

Check out this great interview with the incredible @aspuru.bsky.social on BNNBloomberg, highlighting a recent publication co-authored by our CTO,
@akshatai.bsky.social ! [Paper: rdcu.be/d68Fs]

Exciting times ahead for Klyne—stay tuned for more! 🚀🔬

t.co/tkLsgjcSDb

🚀 Big news from Klyne!

Check out our CTO’s work—the first quantum generative model for hit discovery!

At Klyne, we build affordable tools for drug discovery:
✨ Pay-as-you-go (no licensing fees, ~10x cheaper)
💡 Expert team for every stage
📩 [klyne@klyne.ai]

Thrilled to welcome @akshatai.bsky.social to Klyne! 🚀

Stay tuned for exciting science updates. Have biotech questions or needs? We're here to help: klyne@klyne.ai